EFGARTIGIMOD ALFA
Drug Details
- Generic Name
- EFGARTIGIMOD ALFA
- Brand Names
- VYVGART
- Application Number
- BLA761195
- Sponsor
- Lonza Biologics Tuas Pte.Ltd.
- NDC Codes
- 2
- Dosage Forms
- LIQUID, INJECTION
- Routes
- INTRAVENOUS
- Active Ingredients
- EFGARTIGIMOD ALFA
Indications and Usage
1 INDICATIONS AND USAGE VYVGART HYTRULO is indicated for the treatment of adult patients with: generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive chronic inflammatory demyelinating polyneuropathy (CIDP) VYVGART HYTRULO is a combination of efgartigimod alfa, a neonatal Fc receptor blocker, and hyaluronidase, an endoglycosidase, indicated for the treatment of adult patients with: generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive ( 1 ) chronic inflammatory demyelinating polyneuropathy (CIDP) ( 1 )